Vascular Complications in Children From T1D Diagnosis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age8-18
SponsorUniversity of British Columbia
About this trial
Cardiovascular disease is a complication of type 1 diabetes (T1D), a life-long disease, usually diagnosed in childhood. The goal of this project is to determine the timing and factors leading to vascular damage in children from T1D diagnosis.
Eligibility criteria
Qualifiers
Between the ages of 8-18 years
Within 14 weeks of type 1 diabetes diagnosis
Ability and willingness to undergo non-invasive arterial stiffness assessment for 1hr and willingness to wear the 24-h automated blood pressure monitoring (ABPM) device.
Disqualifiers
Other cardiometabolic or endocrine diseases diagnosis (type 2 diabetes; familial disorders of cholesterol metabolism; lupus)
Other genetic syndromes (Down Syndrome; Prader-Willi)
Eating disorder diagnosis
Transgender children taking hormone blockers or exogenous sex steroids
Trial design
Treatments tested in this trial
- Not listed
Trial groups
150 Participants
are grouped into 1 trial groupSponsors and collaborators
University of British Columbia
Lead sponsor
Canadian Institutes of Health Research (CIHR)
Collaborator
BC Children's Hospital Research Institute
Collaborator
Source ClinicalTrials.gov